FREE ACCESS

Sign in with Google to continue in IP News.

Google SSO gives you the quickest path into the IIPLA newsroom, your reading access, and member-level continuity across articles. The full login page is still available if you prefer another option.

By continuing you agree to our terms and privacy policy.

Already have an account? Log in · Create account

Members-only content

IIPLA News
Saturday, May 2, 2026

U.S. Maintains India on Priority IP Watch List Amid Ongoing Disputes Over Drug Patents

Special 301 Report Highlights Persistent Tensions Between Washington and New Delhi on Pharmaceutical IP and Access to Medicines

IIPLA News Deskanonymous access0 articles left this week
U.S. Maintains India on Priority IP Watch List Amid Ongoing Disputes Over Drug Patents
Sign In To Continue

You have reached the guest article limit.

Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.

The United States has once again placed India on its Priority Watch List in the 2024 Special 301 Report, citing ongoing concerns over India's pharmaceutical patent policies, data protection, and enforcement mechanisms. The move underscores a longstanding divide between the two nations over balancing intellectual prope…
Related Coverage

Continue in the newsroom

Back to newsroom
PatentsUK

Companies House and IPO Alert Businesses to Beware of Fraudulent Payment Demands

Companies House and the Intellectual Property Office (IPO) have jointly issued a warning to UK businesses about unsolicited payment requests. These fraudulent invoices often mimic official correspondence, demanding inflated fees for services that are either free or available at lower costs through legitimate governmen…

Friday, May 22, 2026